The Assessment of Movement Disorders Utilizing Live Two-Way Video

This study is currently recruiting participants.
Verified January 2013 by North Shore Long Island Jewish Health System
Sponsor:
Information provided by (Responsible Party):
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT01467089
First received: October 31, 2011
Last updated: January 14, 2013
Last verified: January 2013

October 31, 2011
January 14, 2013
November 2011
June 2013   (final data collection date for primary outcome measure)
  • Abnormal Involuntary Movement Scale (AIMS) when done in-person versus via two-way video [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • Modified Simpson Angus Scale (mSAS) short version when done in-person versus via two-way video [ Time Frame: Baseline ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01467089 on ClinicalTrials.gov Archive Site
the correlation between the short version and full version of the Modified Simpson Angus Scale (mSAS) [ Time Frame: Baseline ] [ Designated as safety issue: No ]
total score of short version-Modified Simpson Angus Scale vs. total score of full version-Modified Simpson Angus Scale
Same as current
Not Provided
Not Provided
 
The Assessment of Movement Disorders Utilizing Live Two-Way Video
The Assessment of Movement Disorders Utilizing Live Two-Way Video

The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person

Extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) are one of the most frequent and troublesome adverse events when taking antipsychotic agents. The investigators aim in this study to determine if the investigators can conduct examinations for EPS and TD remotely using live two-way video. It is potentially beneficial for patients, especially those who are located far away from psychiatrists if they could be seen by trained clinicians and assessed for EPS and TD via two-way video in the future. Participants will be asked to have a medical assessment which consists of simple questions and some examination of their movements via two-way video and in person. The investigators will compare the results of video examinations with the results of live examinations.

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

40 patients with schizophrenia will be recruited via in- and outpatient psychiatry service of The Zucker Hillside Hospital.

Tardive Dyskinesia
Other: Two way video assessment
Participants will be assessed extrapyramidal symptoms and tardive dyskinesia
schizophrenia

Inclusion Criteria: Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and that have been compliant for the past week. Patients will be referred by their treating doctors if they have some evidence of movement disorder based on the physician's clinical judgment. We will also include 25% of the sample without any evidence of movement disorder.

Exclusion Criteria: Patients who have medical conditions which make it difficult to perform a physical examination. Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.

Intervention: Other: Two way video assessment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
40
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and
  • That have been compliant for the past week.

Exclusion Criteria:

  • Patients who have medical conditions which make it difficult to perform a physical examination.
  • Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Both
18 Years to 75 Years
No
Contact: Taishiro Kishimoto, MD/PhD 718-470-8386 Tkishimoto@nshs.edu
United States
 
NCT01467089
11-243B
No
North Shore Long Island Jewish Health System
North Shore Long Island Jewish Health System
Not Provided
Principal Investigator: Tashiro Kishimoto, MD/PhD North Shore Long Island Jewish Health System
North Shore Long Island Jewish Health System
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP